Avicanna Inc. (FRA:0NN)

Germany · Delayed Price · Currency is EUR

0.1060

0.00 (0.00%)

Last updated: Feb 23, 2026, 8:14 AM CET

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	25.46M	16.79M	4.05M	3.27M	1.57M
Pharmaceuticals Growth	51.62%	314.82%	23.83%	108.20%	-
Total	25.46M	16.79M	4.05M	3.27M	1.57M
Total Growth	51.62%	314.82%	23.83%	108.20%	833.16%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Canada	23.54M	16.43M	-	-	-
Canada Growth	43.28%	-	-	-	-
International	1.92M	364.42K	-	-	-
International Growth	427.59%	-	-	-	-
South America	-	-	1.03M	981.50K	-
South America Growth	-	-	4.96%	-	-
North America	-	-	2.98M	2.26M	-
North America Growth	-	-	32.18%	-	-
Rest of World	-	-	35.41K	31.19K	-
Rest of World Growth	-	-	13.51%	-	-
Total	25.46M	16.79M	4.05M	3.27M	-
Total Growth	51.62%	314.82%	23.83%	-	-

Source: S&P Global Market Intelligence.